| |
Education
1996, Graduated from Hacettepe University, Medical School
1997-2002 certified in Infectious Diseases and Clinical Microbiology
2002-2007 worked as an Infectious Diseases and Clinical Microbiology specialist in Baskent University hospital
2007 certified as Associate Professor of Medicine
2013 certified as Professor of Medicine
Publications
1. Arslan H;Kurt Azap Ö;Ergönül Ö. Timurkaynak F on behalf of Urinary Tract Study Group. Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey J Antimicrob Chemoterapy 56(5); 914-8 (2005)
2. Timurkaynak F;Can F;Azap OK; Demirbilek M;Arslan H;Karaman SO. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units. Int J Antimicrob Agents 2; 224-8 (2006)
3. Kurt Azap Ö;Timurkaynak F;Sezer S;Çağır Ü;Yapar G;Arslan H;Özdemir N. Value of automatized blood culture systems in the diagnosis of continuous ambulatory dialysis peritonitis Transplant Proc 38; 411-2 (2006)
4. Akova YA;Altan-Yaycıoğlu R;Yılmaz G;Azap OK;Haberal M. “Opportunistic posterior uveal infections in renal transplant patients”;Transplant Proc 38;1348-1353 (2006).
5. Senger SS;Arslan H;Azap OK;Timurkaynak F;Cağir U;Haberal M.Urinary tract infections in renal transplant recipients.Transplant Proc 39; 1016-7 (2007).
6. Kurt Azap Ö;Arslan H;Karaman S;Turhan T. Risk Factors for Fecal Carriage of extended-Spectrum Beta-Lactamase Producing Escherichia coli and Klebsiella spp. in the Community. Turkish J Med Sci 37; 31-8 (2007).
7. Arslan H;Kuru İnci E;Kurt Azap Ö;Karakayalı H;Torgay A;Haberal M. “Etiologic agents of diarrhea in solid organ recipients”;Transpl Infect Dis 9; 270-5 (2007).
8. Demirbilek M;Timurkaynak F;Can F;Azap Ö;Arslan H. Biofilm production and antifungal susceptibility patterns of Candida species isolated from hospitalized patients Mikrobiyol Bült 41; 261-9 (2007).
9. Timurkaynak F;Arslan H;Azap OK;Senger SS;Başaran O;Karaman SO;Haberal M.In vitro activity of tigecycline against resistant micro-organisms isolated from burn patients. Burns 34; 1033-6 (2008).
10. Ada S;Seçkin D;Azap Ö;Budakoğlu İ;Haberal M.Prevalence of cutaneous bacterial infections and nasal carriage of Staphylococcus aureus in recipients of renal transplants. Clin Exp Dermatol 34; 156-60 (2009).
11. Ben-Ami R;Rodriguez-Bano J;Arslan H;Pitout JD;Quentin C;Calbo ES;Azap ÖK;Arpin C;Pascual A;Livermore DM;Garau J;Carmeli Y. A multinational survey of risk factors for infection with extended-spectrum beta-lactamase-producing enterobacteriaceae in nonhospitalized patients. Clin Infect Dis 49; 682-90 (2009).
12. Azap OK;Arslan H;Serefhanoğlu K;Colakoğlu S;Erdoğan H;Timurkaynak F;Senger SS. Risk factors for extended-spectrum beta-lactamase positivity in uropathogenic Escherichia coli isolated from community-acquired urinary tract infections. Clin Microbiol Infect 16; 147-51 (2010).
13. Spondylodiscitis and endocarditis caused by S. vestibularis.Tufan MA;Hamide KK;Duygu EB;Ozlem A;Kadir T;Eftal YA.Braz J Infect Dis. 2010 Jul-Aug;14(4):377-9.
14. Bauer MP;Notermans DW;van Benthem BH;Brazier JS;Wilcox MH;Rupnik M;Monnet DL;van Dissel JT;Kuijper EJ; ECDIS Study Group(Allerberger F;Hartman G;Hell M;Wechsler-Fördös A;Delmee M;Gordts B;Laffineur K;Ivanova K;Marina M;Dzhigosheva E;Filefski G;Matica B;Golubic D;Punda-Polic V;Andrasevic AT;Maikanti-Charalampous P;Bagazouni D;Ny? O;Mejzlíkova L;Geigerova L;Olsen KE;Brock I;Holt H;Thomsen MK;Jyrna-Ellam M;Virolainen-Julkunen A;Mikkola J;Mattila E;Broas M;Petrovska M;Barbut F;Descamps D;Canone JP;Lalande V;Lemée L;Cavalie L;Kleinkauf N;Kola A;Knüfermann R;Kist M;Fenner I;Rodloff A;von Eichel-Streiber C;Borgmann S;Michael R;Malamou-Lada E;Orfanidou M;Avlami A;Kanellopoulou M;Nagy E;Konkoly-Thege M;Terhes G;Lenke S;Hardarson H;Hardardottir H;Fitzpatrick F;Skally M;Smyth E;Fenelon L;Schaffer K;Cormican M;Mastrantonio P;Raglio A;Nicoletti P;Dettori G;Mazzella P;Zaccaria T;Balode AO;Aksenoka K;Zvingelis G;Liepins M;Lee C;Mossong J;Even J;Hakim A;Caruana P;Kuijper EJ;Debast SB;Bloembergen P;Harmanus C;Sanders I;Ingrebretsen A;Iversen BG;Jenum PA;Afset JE;Pituch H;Pawlowska J;Pituch H;Pituch H;Furtado C;Guiomar Moreira R;Machado J;Sancho L;Ribeiro G;Ramos H;Lemeni D;Serban R;Ciocîrlan M;Rafila A;Lesanu G;Danaila E;Szekely E;Melková R;Novakova E;Glosova L;Novakova E;Rupnik M;Zupanc TL;Kevorkijan BK;Lesnicar G;Bouza E;Hernández LA;Abarca J;Ribas AM;Sala IS;García MI;Åkerlund T;Wullt M;Norén T;Weintraub A;Nord C;Widmer AF;Widmer A;Widmer A;Levent B;Kacar S;Hascelik G;Sener B;Azap O;Arslan H;Sinirtas M;Akalin H;Ulger N;Soyletir G;Petrovska M;Wilcox M;Patel B;Rooney P;Wiuff C;Gibb A;Coia J;Torné AN;Tüll P.) Clostridium difficile infection in Europe; a hospital-based survey. Lancet 377; 63-73 (2011).
15. Azap O;Togan T;Yesilkaya A;Arslan H;Haberal M. Antimicrobial Susceptibilities of Uropathogen Escherichia coli in Renal Transplant Recipients; Dramatic Increase in Ciprofloxacin Resistance. Transplant Proc. 45; 956-7 (2013).
16. Yeşilkaya A;Azap OK;Demirkaya MH;Ok MA;Arslan H;Akdur A. Bloodstream infections among solid organ transplant recipients: Eight years' experience from a Turkish University Hospital (2013) Balkan Medical Journal, 30 (3), pp. 282-286. Cited 2 times. DOI: 10.5152/balkanmedj.2013.9256
17. Yabanoglu H;Basaran O;Aydogan C;Azap OK;Karakayali F;Moray G. Assessment of the effectiveness of silver-coated dressing, chlorhexidine acetate (0.5%), citric acid (3%), and silver sulfadiazine (1%) for topical antibacterial effects against the multi-drug resistant Pseudomonas aeruginosa infecting full-skin thickness burn wounds on rats (2013) International Surgery, 98 (4), pp. 416-423. Cited 8 times. DOI: 10.9738/INTSURG-D-13-00017.1
18. Evren E;Azap OK;Colakoğlu S;Arslan H. In vitro activity of fosfomycin in combination with imipenem;meropenem;colistin and tigecycline against OXA 48-positive Klebsiella pneumoniae strains. Diagn Microbiol Infect Dis 2013; 13; 208-3 (2013).
19. Yeşilkaya A;Azap OK;Demirkaya MH,Akçıl M;Arslan H;Akdur A. Solid organ nakil alıcılarında kan dolaşımı infeksiyonları; bir Türk üniversite hastanesinin sekiz yıllık deneyimi. Balkan Med J 3 Özkök S;Togan T;Yesilkaya A;Timurkaynak F;Azap ÖK;Arslan H. In vitro susceptibility of tigecycline against multidrug-resistant gram-negative strains; Etest versus agar dilution. Chemotherapy 2014; 60; 151-156
20. Togan T, Azap OK, Durukan E, Arslan H.The prevalence, etiologic agents and risk factors for urinary tract infection among spinal cord injury patients. Jundishapur J Microbiol. 2014 Jan;7(1):e8905. doi: 10.5812/jjm.8905. Epub 2014 Jan 1.
21. Özkök S;Togan T;Yesilkaya A;Timurkaynak F;Azap OK;Arslan H. In vitro susceptibility of tigecycline against multidrug-resistant gram-negative strains: Etest versus agar dilution (2014) Chemotherapy, 60 (3), pp. 151-156. Cited 6 times. DOI: 10.1159/000375440
22. Yesilkaya A;Azap ÖK;Kılıç D;Arslan H;Üner H. A fine line between a major surgery and medical therapy; the diagnosis of sternal tuberculosis. Turk Gogus Kalp Dama 2014; 22; 683-686.
23. Ergönül Ö;Aydin M;Azap A;Başaran S;Tekin S;Kaya Ş;Gülsün S;Yörük G;Kurşun E;Yesilkaya A;Şimşek F;Yılmaz E;Bilgin H;Hatipoğlu Ç;Cabadak H;Tezer Y;Togan T;Karaoğlan İ;İnan A;Engin A;Alışkan HE;Yavuz SŞ;Erdinç Ş;Mulazimoglu L;Azap O;Can F;Akalın H;Timurkaynak H;Turkish Society of Clinical Microbiology and Infectious Diseases;Health care related infections study group. Healthcare-associated gram-negative bloodstream infections; antibiotic resistance and predictors of mortality. J Hosp Infect 2016; 94; 381-385.
24. Can F;Kurt-Azap Ö;İspir P;Nurtop E;Seref C;Loçlar İ;Aktaş ON;Orhan YC;Ergonul O. The clinical impact of ST131 H30-Rx subclone in urinary tract infections due to multidrug-resistant Escherichia coli. J Glob Antimicrob Resist. 2016 Mar;4;49-52. doi; 10.1016/j.jgar.2015.10.006. Epub 2015 Nov 14. PubMed PMID;27436393.
25. Ergönül Ö;Aydin M;Azap A;Başaran S;Tekin S;Kaya Ş;Gülsün S;Yörük G;Kurşun E;Yeşilkaya A;Şimşek F;Yılmaz E;Bilgin H;Hatipoğlu Ç;Cabadak H;Tezer Y;Togan T;Karaoğlan I;İnan A;Engin A;Alışkan HE;Yavuz SŞ;Erdinç Ş;Mulazimoglu L;Azap Ö;Can F;Akalın H;Timurkaynak F; Turkish Society of Clinical Microbiology and Infectious Diseases;Healthcare-Related Infections Study Group. Healthcare-associated Gram-negative bloodstream infections; antibiotic resistance and predictors of mortality. J Hosp Infect. 2016 Dec;94(4);381-385. doi; 10.1016/j.jhin.2016.08.012. Epub 2016 Aug 21. PubMed PMID; 27717604.
26. Gutiérrez-Gutiérrez B;Salamanca E;de Cueto M;Hsueh PR;Viale P;Paño-Pardo JR;Venditti M;Tumbarello M;Daikos G;Pintado V;Doi Y;Tuon FF;Karaiskos I;Machuca I;Schwaber MJ;Azap ÖK;Souli M;Roilides E;Pournaras S;Akova M;Pérez F;Bermejo J;Oliver A;Almela M;Lowman W;Almirante B;Bonomo RA;Carmeli Y;Paterson DL;Pascual A;Rodríguez-Baño J; Investigators from the REIPI/ESGBIS/INCREMENT Group. A Predictive Model of Mortality in Patients With Bloodstream Infections due to Carbapenemase-Producing Enterobacteriaceae. Mayo Clin Proc. 2016 Oct;91(10);1362-1371. doi; 10.1016/j.mayocp.2016.06.024. PubMed PMID; 27712635.
27. Gutiérrez-Gutiérrez B; Bonomo RA;Carmeli Y;Paterson DL;Almirante B;Martínez-Martínez L; Oliver A;Calbo E;Peña C;Akova M;Pitout J;Origüen J;Pintado V;García-Vázquez E;Gasch O; Hamprecht A;Prim N;Tumbarello M;Bou G;Viale P;Tacconelli E;Almela M;Pérez F; Giamarellou H;Cisneros JM;Schwaber MJ;Venditti M;Lowman W; Bermejo J;Hsueh PR;Mora-Rillo M;Gracia-Ahulfinger I;Pascual A;Rodríguez-Baño J; Karaiskos I;Trecarichi EM;Losito AR;Hernández A; Gómez J;Navarro F;Mirelis B;Larrosa N;Puig M;Rucci V;Bartoletti M;Giannella M;Riemenschneider F;Badia, C;Xercavins M;Gálvez J;deCueto M;Salamanca E;Falcone M;Russo A;Daikos G;Paterson DL;Roilides E;Iosifidis E;Doi Y;Tuon FF;SanJuan R;Fernández-Ruiz M;Molina J; González V;Ruizde Gopegui E;Marinescu CI; Fariñas MC;Cano ME;Gozalo M;Paño-Pardo JR;Navarro-San Francisco C;Gómez-Zorrilla S;Tubau F;Pournaras S;Tsakris A;Zarkotou O; Azap ÖK; Souli M;Antoniadou A;Poulakou G;Virmani D;Machuca I;Pérez-Nadales E;Torre-Cisneros J;Helvaci Ö;Sahin AO;Cantón R;Ruiz P;Fontanals D;Jové E. Ertapenem for the treatment of bloodstream infections due to ESBL-producing Enterobacteriaceae: A multinational pre-registered cohort study (2016) Journal of Antimicrobial Chemotherapy, 71 (6), pp. 1672-1680. Cited 15 times. DOI: 10.1093/jac/dkv502
28. Gutiérrez-Gutiérrez B;Pérez-Galera S;Salamanca E;De Cueto M;Calbo E;Almirante B;Viale P;Oliver A;Pintado V;Gasch O;Martínez-Martínez L;Pitout J;Akova M;Peña C;Molina J; Hernández, A., Venditti, M., Prim, N., Origüen, J., Bou, G., Tacconelli, E., Tumbarello, M., Hamprecht, A., Giamarellou, H., Almela, M., Pérez, F., Schwaber, M.J., Bermejo, J., Lowman, W., Hsueh, P.-R., Mora-Rillo, M., Natera, C., Souli, M., Bonomo, R.A., Carmeli, Y., Paterson, D.L., Pascual, A., Rodríguez-Baño, J., Gálvez, J., Del Toro, M.D., Retamar, P., Falcone, M., Russo, A., Daikos, G., Karaiskos, I., Trecarichi, E.M., Losito, A.R., Paterson, D.L., García-Vázquez, E., Gómez, J., Roilides, E., Iosifidis, E., Doi, Y., Tuon, F.F., Navarro, F., Mirelis, B., San Juan, R., Fernández-Ruiz, M., Larrosa, N., Puig, M., Cisneros, J.M., González, V., Rucci, V., Ruiz De Gopegui, E., Marinescu, C.I., Fariñas, M.C., Cano, M.E., Gozalo, M., Paño-Pardo, J.R., Navarro-San Francisco, C., Gómez-Zorrilla, S., Tubau, F., Pournaras, S., Tsakris, A., Zarkotou, O., Azap, Ö.K., Antoniadou, A., Poulakou, G., Virmani, D., Torre-Cisneros, J., Pérez-Nadales, E., Gracia-Ahulfinger, I., Helvaci, Ö., Sahin, A.O., Cantón, R., Ruiz, P., Bartoletti, M., Giannella, M., Riemenschneider, F., Badia, C., Xercavins, M., Fontanals, D., Jové, E. A multinational, preregistered cohort study of β-lactam/β-lactamase inhibitor combinations for treatment of bloodstream infections due to extended-spectrum-β-lactamase-producing enterobacteriaceae (2016) Antimicrobial Agents and Chemotherapy, 60 (7), pp. 4159-4169. Cited 35 times. DOI: 10.1128/AAC.00365-16
29. Harris, P.N.A., Pezzani, M.D., Gutiérrez-Gutiérrez, B., Viale, P., Hsueh, P.-R., Ruiz-Garbajosa, P., Venditti, M., Tumbarello, M., Navarro-Francisco, C., Calbo, E., Akova, M., Giamarellou, H., Oliver, A., Almirante, B., Gasch, O., Martínez-Martínez, L., Schwaber, M.J., Daikos, G., Pitout, J., Peña, C., Hernández-Torres, A., Doi, Y., Pérez, F., Tuon, F.F., Tacconelli, E., Carmeli, Y., Bonomo, R.A., Pascual, Á., Paterson, D.L., Rodríguez-Baño, J., del Toro, M.D., Gálvez, J., Falcone, M., Russo, A., Karaiskos, I., Trecarichi, E.M., Losito, A.R., García-Vázquez, E., Gómez, J., Roilides, E., Iosifidis, E., Pournaras, S., Prim, N., Navarro, F., Mirelis, B., Origüen, J., Juan, R.S., Fernández-Ruiz, M., Almela, M., de la Calle, C., Martínez, J.A., Morata, L., Larrosa, N., Puig-Asensio, M., Bou, G., Molina, J., González, V., Bermejo, J., Rucci, V., de Gopegui, E.R., Marinescu, C.I., Fariñas, M.C., Cano, M.E., Gozalo, M., Paño-Pardo, J.R., Mora-Rillo, M., Gómez-Zorrilla, S., Tubau, F., Tsakris, A., Zarkotou, O., Antoniadou, A., Poulakou, G., Souli, M., Lowman, W., Virmani, D., Torre-Cisneros, J., Machuca, I., Gracia-Ahufinger, I., Azap, Ö.K., Helvaci, Ö., Sahin, A.O., Cantón, R., Pintado, V., Bartoletti, M., Giannella, M., Peter, S., Hamprecht, A., Badia, C., Xercavins, M., Fontanals, D., Jové, E. Geographical variation in therapy for bloodstream infections due to multidrug-resistant Enterobacteriaceae: a post-hoc analysis of the INCREMENT study (2017) International Journal of Antimicrobial Agents, 50 (5), pp. 664-672. DOI: 10.1016/j.ijantimicag.2017.08.005
30. Palacios-Baena, Z.R., Gutiérrez-Gutiérrez, B., Calbo, E., Almirante, B., Viale, P., Oliver, A., Pintado, V., Gasch, O., Martínez-Martínez, L., Pitout, J., Akova, M., Peña, C., Molina Gil-Bermejo, J., Hernández, A., Venditti, M., Prim, N., Bou, G., Tacconelli, E., Tumbarello, M., Hamprecht, A., Giamarellou, H., Almela, M., Pérez, F., Schwaber, M.J., Bermejo, J., Lowman, W., Hsueh, P.-R., Paño-Pardo, J.R., Torre-Cisneros, J., Souli, M., Bonomo, R.A., Carmeli, Y., Paterson, D.L., Pascual, Á., Rodríguez-Baño, J., Gálvez, J., Falcone, M., Russo, A., Daikos, G., Trecarichi, E.M., Losito, A.R., Gómez, J., Iosifidis, E., Roilides, E., Karaiskos, I., Doi, Y., Tuon, F.F., Navarro, F., Mirelis, B., Martínez, J.A., De La Calle, C., Morata, L., San Juan, R., Fernández-Ruiz, M., Larrosa, N., Puig, M., Molina, J., González, V., Rucci, V., Ruiz De Gopegui, E., Marinescu, C.I., Fariñas, M.C., Cano, M.E., Gozalo, M., Mora-Rillo, M., Gómez-Zorrilla, S., Tubau, F., Pournaras, S., Tsakris, A., Zarkotou, O., Azap, Ö.K., Antoniadou, A., Poulakou, G., Virmani, D., Cano, Á., Machuca, I., Helvaci, Ö., Sahin, A.O., Ruiz-Garbajosa, P., Bartoletti, M., Giannella, M., Peter, S., Badia, C., Xercavins, M., Fontanals, D., Jové, E. Empiric Therapy with Carbapenem-Sparing Regimens for Bloodstream Infections due to Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae: Results from the INCREMENT Cohort (2017) Clinical Infectious Diseases, 65 (10), pp. 1615-1623. Cited 1 time. DOI: 10.1093/cid/cix606
31. Aydin M;Ergönül Ö;Azap A;Bilgin H;Aydın G;Çavuş SA;Demiroğlu YZ;Çalışkan HE;Memikoğlu O;Menekşe Ş;Kaya Ş;Demir NA;Karaoğlan İ;Başaran S;Hatipoğlu Ç;Erdinç Ş;Yılmaz E;Tümtürk A;Tezer Y;Demirkaya H;Çakar ŞE;Keske Ş;SudaTekin;Yardımcı C;Karakoç Ç;Ergen P;Azap Ö;Mülazımoğlu L;Ural O;Can F;Akalın H; Turkish Society of Clinical Microbiology and Infectious Diseases,Health care related infections study group;Turkey. Rapid Emergence of ColistinResistance and its Impact on Mortality in Healthcare-associated Infections. J Hosp Infect. 2017 Dec 14. pii; S0195-6701(17)30641-2. doi;10.1016/j.jhin.2017.11.014. [Epub ahead of print] PubMed PMID; 29248504.
32. Gutiérrez-Gutiérrez B;Salamanca E;de Cueto M;Hsueh PR;Viale P;Paño-Pardo JR;Venditti M;Tumbarello M;Daikos G;Cantón R;Doi Y;Tuon FF;Karaiskos I;Pérez-Nadales E;Schwaber MJ;Azap ÖK;Souli M;Roilides E;Pournaras S;Akova M;Pérez F;Bermejo J;Oliver A;Almela M;Lowman W;Almirante B;Bonomo RA;Carmeli Y;Paterson DL;Pascual A;Rodríguez-Baño J; REIPI/ESGBIS/INCREMENT Investigators. Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT); a retrospective cohort study. Lancet Infect Dis. 2017 Jul;17(7);726-734. doi; 10.1016/S1473-3099(17)30228-1. Epub 2017 Apr 22. PubMed PMID; 28442293.
33. Yeşilkaya A;Azap Ö;Aydın M;Akçil Ok M. Epidemiology;species distribution;clinical characteristics and mortality of candidaemia in a tertiary care university hospital in Turkey;2007-2014. Mycoses. 2017 Jul;60(7);433-439. doi;10.1111/myc.12618. Epub 2017 Mar 24. PubMed PMID; 28338249.
34. Can F;Menekse S;Ispir P;Atac N;Albayrak O;Demir T;Karaaslan DC;Karahan SN;Kapmaz M;Kurt Azap O;Timurkaynak F;Simsek Yavuz S;Basaran S;Yoruk F;Azap A;Koculu S;Benzonana N;Lack NA;Gönen M;Ergonul O. Impact of the ST101clone on fatality among patients with colistin-resistant Klebsiella pneumoniae infection. J Antimicrob Chemother. 2018 Feb 3. doi; 10.1093/jac/dkx532. [Epub ahead of print] PubMed PMID; 29415120.
35. Aydın M;Ergönül Ö;Azap A;Bilgin H;Aydın G;Çavuş SA;Demiroğlu YZ;Alışkan HE;Memikoğlu O;Menekşe Ş;Kaya Ş;Demir NA;Karaoğlan İ;Başaran S;Hatipoğlu Ç;Erdinç Ş;Yılmaz E;Tümtürk A;Tezer Y;Demirkaya H;Çakar ŞE;Keske Ş;Tekin S;Yardımcı C;Karakoç Ç;Ergen P;Azap Ö;Mülazımoğlu L;Ural O;Can F;Akalın H. Rapid emergence of colistin resistance and its impact on fatality among healthcare-associated infections (2018) Journal of Hospital Infection, 98 (3), pp. 260-263. DOI: 10.1016/j.jhin.2017.11.014
36. Memikoğlu KO;Bayar B;Kurt Ö;Çokça F. Metisiline dirençli Staphylococcus aureus suşlarının fusidik asit ve trimetoprim-sulfametoksazole in vitro duyarlılığı. Mikrobiyoloji Bülteni 36; 141-5 AAW (2002).
37. Aydın E;Hızal E;Akkuzu B; Azap O. Risk of contamination of nasal sprays in otolaryngologic practice. BMC Ear;Nose and Throat Disorders 7; 2 (2007).
38. Albayrak F;Memikoğlu OK;Kurt Ö;Çokça F. A case of anthrax meningitis. Scandinavian Journal of Infectious Diseases 34; 627-8 (2002).
39. Arslan H;Kurt Azap Ö;Ergin F;Karaman SÖ;Oruç E. In vitro activity of daptomycin against a range of Staphylococcus aureus and Enterococcus isolates; First results from Turkey Int J Antimicrob Agents 23; 642-3 (2004)
40. Kurt Azap Ö;Arslan H;Timurkaynak F;Yapar G;Oruç E;Çağır Ü. Incidence of inducible clindamycin resistance in staphylococci; First results from Turkey (Research Note) Clinical Microbiology and Infection 11; 582-4 (2005)
41. Kurt Azap Ö;Arslan H;Timurkaynak F. Rifampin induced arthritis. Journal of Infection 51; 261-2 (2005).
42. Kurt Azap Ö;Yapar G;Timurkaynak F;Arslan H;Sezer S;Özdemir H. Gemella morbillorum peritonitis in a patient being treated with continuous ambulatory peritoneal dialysis Nephrology;Dialysis and Transplantation 20; 853-4 (2005)
43. Turan H;Arslan H;Azap OK;Şerefhanoğlu K;Uncu H. In vitro antibacterial activity of tigecycline in comparison with doxycycline against Brucella spp. International Journal of Antimicrobrobial Agents 30; 186-7 (2007).
44. İbiş A;Sezer S;Tutal E;Azap OK;Özdemir FN. Peritonitis due to Streptococcus anginosus in patients treated with CAPD; a report of two cases. Peritoneal Dialysis International; 28; 315-6 (2008).
45. Avcı Z;Alioğlu B;Anuk D;Özbek ÖY;Azap OK;Özbek N. Double invasive fungal infection and typhlitis in children with acute lymphoblastic leukemia. Pediatric Hematology and Oncology 25; 99-106 (2008).
46. Yeşilkaya A;Kurt Azap Ö;Arslan H;Yağcı-Çağlayık D;Uyar Y;Korukluoğlu G;Özkul A. Ölümcül seyreden Batı Nil virüsü olgusu. Mikrobiyol Bül 46; 488-92 (2012).
47. Yeşilkaya A;Azap ÖK;Pirat B;Gültekin B;Arslan H. A rare Case of Endocarditis; Streptococcus pyogenes. Balkan Med J 29; 331-3 (2012).
48. Toprak SK;Erdoğan E;Kurt Azap Ö. Mirtazapine-induced thrombocytopenia. Turk J Hematol 29; 297-8 (2012).
49. Azap ÖK;Otlu B;Yeşilkaya A;Yakupoğulları Y. Detection of OXA-48-like carbapenemase-producing Klebsiella pneumoniae in atertiary care center in Turkey; Molecular characterizxation and epidemiology. Balkan Med J 2013; 30; 259-60.
50. Atalay B;Azap Ö;Çekinmez M;Caner H;Haberal M. Nocardial epidural abscess of the thoracic spinal cord and review of the literature. Journal of Infection and Chemotherapy 2005; 11; 169-71. (Case report)
51. Özışık L;Akman B;Huddam B;Kurt Azap Ö;Bilgiç A;sezer S;Özdemir N. Isolated Brucella peritionitis. American Journal Kidney Diseases 2006; 47; e55-e56 (Case report)
52. Küpeli E;Bozkurt E;Azap Ö;Eyüboğlu FÖ. Mycobacterium fortiutum infection presenting as community-acquired pneumonia in an immunocompetent host. J Bronchol Intervent Pulmonol 17; 356-8 (2010)
53. Toprak S;kaya E;Azap Ö;Atılgan AO;Kaşkari D;Tek İ. Kikuchi-Fujimoto Disease. Orta Doğu Medical Journal 2011; 3; 97-9.
|
|
